Morepen Laboratories advanced 3.77% to Rs 18.44 after the company said it received ISO-13485 certification for its medical devices manufacturing facility at Baddi in Himachal Pradesh.
Morepen Laboratories on 30 April 2020 said it has received the ISO-13485 certification from BSI (British Standards Institution, U.K.) for its medical devices manufacturing facility at Baddi (Himachal Pradesh). The certification has been awarded for the manufacturing, distribution and after sales service of all point-of-care diagnostic medical devices and their accessories manufactured at the company's facility in Baddi. The manufacturing facility and its management systems were rigorously audited by experts and the company has been awarded the certification based on the comprehensive audit procedures undertaken by the notified body.The ISO-13485 standard is an international standard which specifies requirements for quality management systems (QMS) that are to be used by an organization involved in one or more stages of the life-cycle of a medical device. This certification is recognized by most regulators across the globe including those in the United Kingdom and the European Union. Compliance with this standard ensures the consistent production, delivery and after sales service of medical devices that are safe for their intended purpose.
On a consolidated basis, the company's net profit rose 21.3% to Rs 10.82 crore on an 8.4% increase in net sales to Rs 230.06 crore in Q3 December 2019 over Q3 December 2018.
Morepen Laboratories is a pharmaceutical company. It manufactures and sells active pharmaceutical ingredients (APIs), home diagnostics and finished formulations to 50-plus countries.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)